Ex Vivo Cryoimaging for Plaque Characterization  by Faramarzalian, Ali et al.
Letters to the Editor J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 4 , 2 0 1 4
A P R I L 2 0 1 4 : 4 2 9 – 3 3
430During the study period, a total of 2,323 TTE studies were
performed in 251 LVAD patients. Of them, 10 patients (4.0%)
underwent a total of 12 CE studies (0.5%) (2 patients had repeat
CE examinations). All patients underwent CE due to suboptimal
endocardial border deﬁnition during noncontrast TTE. All but
1 patient was supported by a HeartMate II (Thoratec Corporation,
Pleasanton, California) continuous-ﬂow LVAD, and this patient
was supported by a HeartMate XVE (Thoratec Corporation)
pulsatile-ﬂow LVAD. CE was performed successfully in all patients.
Deﬁnity contrast was used in 9 CE examinations, and Optison was
used in 3. Representative 2-dimensional echocardiography images
before and after contrast administration are shown in Figure 1. The
use of contrast aided image interpretation in 10 CE examinations
(83%) and did not change image interpretation in 2 (17%). CE
contributed to a change in LVAD patient management in 5 ex-
aminations (42%), including adjustment of pump speed in 3 pa-
tients, intensiﬁcation of inotrope support in 1 patient after
identiﬁcation of severe right ventricular systolic dysfunction, and
intensiﬁcation of anticoagulation therapy in 1 patient after identi-
ﬁcation of a previously unrecognized nonobstructive left ventricular
apical thrombus adjacent to the LVAD inﬂow cannula (Fig. 1,
Online Video 1). No adverse events or known side effects of ul-
trasound contrast agents were reported during or after CE in any
patient. Importantly, no changes in device function parameters were
noted during or after CE.
To our knowledge, this is the ﬁrst report to describe the use of
CE in multiple LVAD patients. CE was successfully performed
using a standard imaging protocol used for non-LVAD patients.
Uncertainty regarding both the risk of causing adverse reactions or
device function interference and the feasibility of diagnostic image
acquisition during continuous blood ﬂow into the device cannula has
likely led to a signiﬁcant underuse of CE in this population. Even at
our institution, CE was used in only 0.5% of TTE studies per-
formed on LVAD patients, although it is likely that many more
would have beneﬁted from its use. By comparison, CE is used in
w5% of all resting TTE studies in our laboratory. In summary, CE
was feasible and safe and improved image interpretation in a small
sample of LVAD patients undergoing clinically indicated echocar-
diography. CE should be used as needed during the echocardio-
graphic evaluation of LVAD patients with technically difﬁcult
images.
Nowell M. Fine, MD, Sahar S. Abdelmoneim, MBBCh, MSc,
Amy Dichak, RDCS, Sudhir S. Kushwaha, MD, Soon J. Park, MD, MS,
Sharon L. Mulvagh, MD*
*Division of Cardiovascular Diseases, Department of Medicine, Mayo
Clinic, 200 First Street SW, Rochester, Minnesota 55901. E-mail:
smulvagh@mayo.edu
http://dx.doi.org/10.1016/j.jcmg.2013.08.016
Please note: Dr. Mulvagh has received research grants from Lantheus Medical Imaging.
Dr. Park is a consultant for Thoratec Corporation. All other authors have reported that
they have no relationships relevant to the contents of this paper to disclose.R E F E R E N C E S
1. Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of
Echocardiography Consensus Statement on the Clinical Applications ofUltrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr
2008;21:1179–201; quiz 1281.
2. Moser AR, Hockman D, Magalski A, Main ML, Khumri TM,
Austin BA. Apical pseudoaneurysm following continuous ﬂow left ven-
tricular assist device placement. Circ Heart Fail 2012;5:e53–4.
A P P E N D I X
For a supplemental video, please see the online version of this article.
Ex Vivo Cryoimaging for
Plaque Characterization
Histopathology is the gold standard for the validation of arterial
plaque characterization by in vivo methods. Volumetric comparison
of images with histopathology, however, can be cumbersome and
cost prohibitive. Cryoimaging provides real-time, ultra-high-reso-
lution anatomical bright-ﬁeld and ﬂuorescence data by alternatively
sectioning and imaging a tissue block face (1,2). Plaque morphology
is minimally altered, permitting precise volumetric tissue charac-
terization. Fibrous cap inﬂammation and elastin are important
biomarkers that correlate with plaque stability. With accurate
characterization of these constituents, cryoimaging can detect a
volumetric plaque transition to a vulnerable state.
We sought to characterize ﬁbrous cap inﬂammation and elastin in
coronary plaques by cryoimaging. We also introduce a method for
the use of cryoimaging as an adjuvant for plaque validation through
a single-case volumetric comparison of cross-sections from intra-
vascular optical coherence tomography (OCT) with cryoimaging
and histopathology.
A total of 18 atherosclerotic plaques were evaluated from 10 cor-
onary arteries of male cadavers (mean age 50.2  6.2 years). Vessels
were explanted and stored at 4C no longer than 48 h. A vessel was
ﬁxed to a plastic cylindrical rig and infused with optimal cutting
temperature gel. The optical coherence tomographic imaging cath-
eter was inserted through the ostial end of the vessel, and images
were captured every 200 mm by an automated 10 mm/s pull-back.
Images were screened for ﬁbroatheromatous and ﬁbrous segments
using consensus criteria (3). The start and end frames for plaque were
bookmarked for analysis by cryoimaging. The vessel was sectioned
into 5-cm cylindrical blocks and stored at 80C. Cryoimaging was
executed as previously described (2). Images were acquired in 5-mm
intervals until reaching the plaque of interest. A 3-mm slab was
sectioned and saved for histological analysis. Slabs were frozen
(n ¼ 7) or ﬁxed in 10% formalin and embedded in parafﬁn (n ¼ 11).
Slices were sectioned 7 mm thick and stained. Cryoimaging was
restarted until another plaque was reached or the vessel terminated.
Slides were digitally scanned and reviewed by 1 pathologist
(N.P.Z.). Fibrous caps were stratiﬁed into inﬂamed or noninﬂamed
groups on the basis of 2 thresholds for percent of capsule occupied
by macrophage (0% and 10%). Images from cryoimaging were split
into color channels, and mean intensity was measured over the
ﬁbrous cap pixel area. Univariate and multivariate logistic regression
with stepwise selection were performed. Odds ratios and areas under
the receiver operating characteristic curves were calculated. A p value
<0.05 was considered statistically signiﬁcant.
Methods and representative images from OCT, cryoimaging,
and histopathology are provided in Figure 1. A total of 3,246 optical
coherence tomographic frames, 22,864 cryoimaging frames, and 126
histological slides were evaluated. OCT accurately screened 81%
Figure 1. Illustration of Plaque Evaluation Method: Volumetric Coregistration of Images From OCT, Cryoimaging, and Histopathology
(A) Optical coherence tomography (OCT) was performed, and images were screened for plaque type. This is a longitudinal optical coherence tomographic image with
a ﬁbroatheromatous plaque of interest (4 to 15 mm). Red dashed lines indicate the start (7 mm) and end (10 mm) frames for subsequent histological analysis.
(B) Schematic of cryoimaging. A bookmarked 3-mm segment was sectioned for histological analysis. Examples of coregistered images provided from (C) frames
preceding the region of interest, (D) starting at the region of interest, and (E) within the region of interest. Images in (D) provide the opportunity for frame comparison
among all 3 modalities. Masson’s trichrome was used to assess the ﬁbrous cap (blue), Verhoeff’s Van Gieson for elastin content (yellow-black), anti-CD68 for
macrophage (brown), and anti–smooth muscle actin for smooth muscle cells (dark brown). Lesions per row: (F) dim brown appearance of macrophage (open arrows)
by ﬂuorescence and (G,H) bright green streaks of elastin (closed arrows) by ﬂuorescence. (H) Less inﬂamed ﬁbrous tissue appears homogenously dim by ﬂuorescence
and pink to pale white by bright-ﬁeld (between closed arrows on the right). The asterisk indicates target lipid plaque; slab ¼ 3-mm plaque of interest.
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432(9 of 11) and 86% (6 of 7) of ﬁbroatheromatous and ﬁbrous plaques
compared with histopathology. Two cases were classiﬁed as ﬁbrous
by OCT but ﬁbroatheromatous by histopathology, and 1 case was
classiﬁed as ﬁbroatheromatous by OCT but ﬁbrocalciﬁc by
histopathology.
Macrophages appeared brown with low intensity by ﬂuorescence
and pink to pale white by bright-ﬁeld (Fig. 1f). Elastin appeared as
bright green streaks by ﬂuorescence and pink to pale white by
bright-ﬁeld (Fig. 1g). Cryoimaging green ﬂuorescence was the best
individual marker of inﬂammation at 0% (odds ratio: 0.93; p <
0.05) and 10% (odds ratio: 0.95; p < 0.05) macrophage, with areas
under the curve of 0.958 (95% conﬁdence interval: 0.869 to 1.000;
p < 0.001) and 0.790 (95% conﬁdence interval: 0.516 to 1.000;
p < 0.05), respectively. Using green ﬂuorescence intensity <60 as
positive for inﬂammation (i.e., >0% macrophage), sensitivity was
91.7% (p ¼ 0.003), speciﬁcity 100% (p ¼ 0.016), positive predictive
value 100% (p < 0.001), negative predictive value 85.7% (p ¼ 0.06),
and accuracy 94.4% (p < 0.001).
We demonstrate that less cryoimaging ﬂuorescence correlates
with greater density of macrophage and less elastin. These properties
are consistent with studies using different excitation and emission
wavelengths (4). Although this trial was small, a volumetric
approach for comparing optical coherence tomographic images with
cryoimaging and histopathology was successfully introduced. Early
data yielded sensitivities of OCT within range reported in previous
research. Errors in screening are typically related to misidentiﬁcation
of lipid versus ﬁbrous and calciﬁed plaques (5). Cryoimaging is a
promising adjuvant for plaque characterization on the basis of high
sensitivity and speciﬁcity for these constituents.
Clinical applications of volumetric tissue characterization by cry-
oimaging are numerous. Volume-rendering techniques are being
developed to improve 3-dimensional coregistration between in vivo
modalities and cryoimaging. Tissue volumes may be segmented and
compared quantitatively to obtain more accurate results than by his-
topathology alone. Segmentation of elastin and inﬂammation during
volume renderings may be analyzed via ﬁnite element analysis to
understand effects of plaque deformation on genuine vessel archi-
tecture. Coupling to in vivo imaging modalities provides potential for
understanding the real-time effects of therapeutic intervention (i.e.,
stent deployment) on ﬁbrous cap stress. Fluorescence tagging before
imaging allows volumetric quantiﬁcation of desired cells or proteins.
In conclusion, this pilot study demonstrates that cryoimaging is
capable of detecting ﬁbrous cap inﬂammation with high sensitivity
and speciﬁcity. Potential for macrophage quantiﬁcation was
demonstrated at 2 thresholds. Cryoimaging is a promising adjunct
to histopathology for studies aiming to validate OCT for plaque
characterization.
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In the Footsteps of Virchow
We read with interest the report on “Fat Deposition in Dilated
Cardiomyopathy Assessed by CMR” by Lu et al. (1), because it
describes a phenomenon already observed by Rudolph Virchow in
1858. In his book on cellular pathology, he devotes 2 full chapters to
fatty atrophy of the heart (2). In lecture 16, he describes the fatty
degeneration of the muscular substance of the heart in its different
stages. Here we quote the text verbatim:
You will observe that, even with the naked eye, certain
changes can be recognized in the heart, namely a discol-
oration of its whole substance (which no longer presents
the red hue of muscle, but wears a pale yellow tint), and
besides peculiar spots on the papillary muscles. If you
examine these more closely, you will perceive, in the di-
rection of the primitive fasciculi, short, yellowish streaks
which communicate so as almost to present a plexiform
arrangement, and pervade the substance of the papillary
muscles, whilst they offer a striking contrast to the reddish
colour of proper muscular substance. This is the perfect
form of genuine fatty metamorphosis of the real muscular
substance of the heart, which differs most essentially from
obesity of the heart, in which this organ becomes extremely
fat and adipose tissue here and there so inﬁltrates its walls,
that scarcely any muscle is to be perceived.
Unlike Virchow, the investigators of the present study have not
been able to distinguish between intramyocellular and extra-
myocellular fat. The investigators also elected to omit the metabolic
proﬁles of their patients. This might be of importance because we
identiﬁed a subgroup of heart failure patients with severe metabolic
